Published in Gastroenterol Clin North Am on June 01, 2005
Increased gastrointestinal permeability and gut inflammation in children with functional abdominal pain and irritable bowel syndrome. J Pediatr (2008) 2.15
Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest (2007) 2.09
Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity. Am J Gastroenterol (2009) 2.02
Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut (2006) 1.60
Colonic mucosal immune activity in irritable bowel syndrome: comparison with healthy controls and patients with ulcerative colitis. Dig Dis Sci (2013) 1.48
Irritable bowel syndrome: diagnosis and pathogenesis. World J Gastroenterol (2012) 1.32
Plasticity of enteric nerve functions in the inflamed and postinflamed gut. Neurogastroenterol Motil (2009) 1.21
Neuroinflammation in inflammatory bowel disease. J Neuroinflammation (2010) 1.18
Giardia lamblia-induced changes in gene expression in differentiated Caco-2 human intestinal epithelial cells. Infect Immun (2005) 1.16
Irritable bowel syndrome. Nat Rev Dis Prim (2016) 1.14
Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome. BMC Gastroenterol (2012) 0.97
Patients with irritable bowel syndrome are more burdened by co-morbidity and worry about serious diseases than healthy controls--eight years follow-up of IBS patients in primary care. BMC Public Health (2013) 0.93
Chemo-nociceptive signalling from the colon is enhanced by mild colitis and blocked by inhibition of transient receptor potential ankyrin 1 channels. Br J Pharmacol (2010) 0.92
Afferent hypersensitivity in a mouse model of post-inflammatory gut dysfunction: role of altered serotonin metabolism. J Physiol (2008) 0.92
The epidemiology of obesity and gastrointestinal and other diseases: an overview. Dig Dis Sci (2008) 0.88
HLA-DQ genotype is associated with accelerated small bowel transit in patients with diarrhea-predominant irritable bowel syndrome. Eur J Gastroenterol Hepatol (2011) 0.87
Colitis-induced neuroplasticity disrupts motility in the inflamed and post-inflamed colon. J Clin Invest (2015) 0.86
From cytokines to toll-like receptors and beyond - current knowledge and future research needs in irritable bowel syndrome. J Neurogastroenterol Motil (2010) 0.85
Neural autoantibody evaluation in functional gastrointestinal disorders: a population-based case-control study. Dig Dis Sci (2010) 0.83
Immune activation and gut microbes in irritable bowel syndrome. Gut Liver (2009) 0.82
Irritable bowel syndrome and inflammatory bowel disease overlap syndrome: pieces of the puzzle are falling into place. Intest Res (2016) 0.82
Effect of probiotics on gastrointestinal function: evidence from animal models. Therap Adv Gastroenterol (2009) 0.80
A magic pill? A qualitative analysis of patients' views on the role of antidepressant therapy in inflammatory bowel disease (IBD). BMC Gastroenterol (2012) 0.80
Abdominal bloating and distension: what is the role of the microbiota. Dig Dis Sci (2011) 0.80
Pharmacology of inflammatory pain: local alteration in receptors and mediators. Dig Dis (2010) 0.80
Alosetron, cilansetron and tegaserod modify mesenteric but not colonic blood flow in rats. Br J Pharmacol (2009) 0.79
Enhanced excitability of guinea pig inferior mesenteric ganglion neurons during and following recovery from chemical colitis. Am J Physiol Gastrointest Liver Physiol (2012) 0.79
Anti-Inflammatory Activities of a Chinese Herbal Formula IBS-20 In Vitro and In Vivo. Evid Based Complement Alternat Med (2012) 0.79
Dietary Triggers in Irritable Bowel Syndrome: Is There a Role for Gluten? J Neurogastroenterol Motil (2016) 0.77
Diagnosis and management of functional symptoms in inflammatory bowel disease in remission. World J Gastrointest Pharmacol Ther (2016) 0.75
Overweight and constipation in adolescents. BMC Gastroenterol (2011) 0.75
Mind-Body Interventions for Pediatric Inflammatory Bowel Disease. Children (Basel) (2017) 0.75
Diagnostic Delay in Romanian Patients with Inflammatory Bowel Disease: Risk Factors and Impact on the Disease Course and Need for Surgery. J Crohns Colitis (2015) 0.75
Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon. Dig Dis Sci (2015) 0.75
Lipopolysaccharide induces visceral hypersensitivity: role of interleukin-1, interleukin-6, and peripheral corticotropin-releasing factor in rats. J Gastroenterol (2016) 0.75
Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science (2009) 4.45
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology (2004) 4.05
Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology (2010) 3.32
Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology (2011) 3.29
The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology (2011) 2.71
Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut (2012) 2.60
The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models. Inflamm Bowel Dis (2014) 2.46
Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut (2010) 2.21
Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology (2006) 2.07
Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology (2002) 2.02
Mechanisms underlying the maintenance of muscle hypercontractility in a model of postinfective gut dysfunction. Gastroenterology (2005) 1.86
Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology (2010) 1.85
The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology (2006) 1.75
Role of IL-4, IL-13, and STAT6 in inflammation-induced hypercontractility of murine smooth muscle cells. Am J Physiol Gastrointest Liver Physiol (2002) 1.72
Prevalence of uninvestigated dyspepsia 8 years after a large waterborne outbreak of bacterial dysentery: a cohort study. Gastroenterology (2010) 1.58
Immune-mediated neural dysfunction in a murine model of chronic Helicobacter pylori infection. Gastroenterology (2002) 1.50
Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction. Gastroenterology (2004) 1.38
Fundamentals of neurogastroenterology: basic science. Gastroenterology (2006) 1.34
Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression. J Clin Invest (2008) 1.33
Loss of hepatocyte-nuclear-factor-4alpha affects colonic ion transport and causes chronic inflammation resembling inflammatory bowel disease in mice. PLoS One (2009) 1.32
Reactivation of inflammatory bowel disease in a mouse model of depression. Gastroenterology (2009) 1.27
Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction. Gastroenterology (2004) 1.17
Transgenomic metabolic interactions in a mouse disease model: interactions of Trichinella spiralis infection with dietary Lactobacillus paracasei supplementation. J Proteome Res (2006) 1.16
Role of gut-brain axis in persistent abnormal feeding behavior in mice following eradication of Helicobacter pylori infection. Am J Physiol Regul Integr Comp Physiol (2009) 1.15
TGF-beta1 gene transfer to the mouse colon leads to intestinal fibrosis. Am J Physiol Gastrointest Liver Physiol (2005) 1.15
Vagus nerve integrity and experimental colitis. Am J Physiol Gastrointest Liver Physiol (2007) 1.13
Sensitization to gliadin induces moderate enteropathy and insulitis in nonobese diabetic-DQ8 mice. J Immunol (2011) 1.12
Polymeric binders suppress gliadin-induced toxicity in the intestinal epithelium. Gastroenterology (2008) 1.12
The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes (2012) 1.12
Modulatory effects of estrogen in two murine models of experimental colitis. Am J Physiol Gastrointest Liver Physiol (2002) 1.12
The protective effect of the vagus nerve in a murine model of chronic relapsing colitis. Am J Physiol Gastrointest Liver Physiol (2007) 1.11
Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment. Can J Gastroenterol (2007) 1.07
Commensal and probiotic bacteria influence intestinal barrier function and susceptibility to colitis in Nod1-/-; Nod2-/- mice. Inflamm Bowel Dis (2011) 1.05
A case for an immunological basis for irritable bowel syndrome. Gastroenterology (2002) 1.04
Interleukin-4- and -13-induced hypercontractility of human intestinal muscle cells-implication for motility changes in Crohn's disease. Am J Physiol Gastrointest Liver Physiol (2004) 1.03
The copolymer P(HEMA-co-SS) binds gluten and reduces immune response in gluten-sensitized mice and human tissues. Gastroenterology (2011) 1.03
NK cells require type I IFN receptor for antiviral responses during genital HSV-2 infection. Cell Immunol (2011) 1.02
Cytokine modulation of muscarinic receptors in the murine intestine. Am J Physiol Gastrointest Liver Physiol (2007) 1.02
Editorial: Can gluten contribute to irritable bowel syndrome? Am J Gastroenterol (2011) 1.01
Peripheral mechanisms in irritable bowel syndrome. N Engl J Med (2013) 1.01
Antidepressants attenuate increased susceptibility to colitis in a murine model of depression. Gastroenterology (2006) 1.01
Visceral pain perception is determined by the duration of colitis and associated neuropeptide expression in the mouse. Gut (2006) 0.99
An outbreak of acute bacterial gastroenteritis is associated with an increased incidence of irritable bowel syndrome in children. Am J Gastroenterol (2010) 0.97
The incidence of irritable bowel syndrome among community subjects with previous acute enteric infection. Dig Dis Sci (2006) 0.97
Relative contributions of NOS isoforms during experimental colitis: endothelial-derived NOS maintains mucosal integrity. Am J Physiol Gastrointest Liver Physiol (2004) 0.96
CD4+ T-cell modulation of visceral nociception in mice. Gastroenterology (2006) 0.96
Larazotide acetate regulates epithelial tight junctions in vitro and in vivo. Peptides (2012) 0.95
Pathology of interstitial cells of Cajal in relation to inflammation revealed by ultrastructure but not immunohistochemistry. Am J Pathol (2002) 0.95
Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications. Pharmacol Res (2012) 0.94
Testing for gluten-related disorders in clinical practice: the role of serology in managing the spectrum of gluten sensitivity. Can J Gastroenterol (2011) 0.93
Differential induction of antimicrobial REGIII by the intestinal microbiota and Bifidobacterium breve NCC2950. Appl Environ Microbiol (2013) 0.92
The chronic gastrointestinal consequences associated with campylobacter. Curr Gastroenterol Rep (2012) 0.91
Irritable bowel syndrome and probiotics: from rationale to clinical use. Curr Opin Gastroenterol (2005) 0.91
Loss of hepatocyte-nuclear-factor-1alpha impacts on adult mouse intestinal epithelial cell growth and cell lineages differentiation. PLoS One (2010) 0.90
Hydrogen sulfide and resolution of acute inflammation: A comparative study utilizing a novel fluorescent probe. Sci Rep (2012) 0.89
Microbial-gut interactions in health and disease. Irritable bowel syndrome. Best Pract Res Clin Gastroenterol (2004) 0.88
Ecobiotherapy Rich in Firmicutes Decreases Susceptibility to Colitis in a Humanized Gnotobiotic Mouse Model. Inflamm Bowel Dis (2015) 0.86
Interleukin-15 and NK1.1+ cells provide innate protection against acute Salmonella enterica serovar Typhimurium infection in the gut and in systemic tissues. Infect Immun (2008) 0.85
The role of luminal factors in the recovery of gastric function and behavioral changes after chronic Helicobacter pylori infection. Am J Physiol Gastrointest Liver Physiol (2008) 0.85
Lymphocyte-mediated regulation of beta-endorphin in the myenteric plexus. Am J Physiol Gastrointest Liver Physiol (2006) 0.83
Prevention measures and exploratory pharmacological treatments of celiac disease. Am J Gastroenterol (2010) 0.83
Adoptive transfer of macrophage from mice with depression-like behavior enhances susceptibility to colitis. Inflamm Bowel Dis (2011) 0.82
IL-4 gene transfer to the small bowel serosa leads to intestinal inflammation and smooth muscle hyperresponsiveness. Am J Physiol Gastrointest Liver Physiol (2007) 0.81
Extraintestinal manifestations of celiac disease. Dig Dis (2015) 0.81
Gut microbes and adverse food reactions: Focus on gluten related disorders. Gut Microbes (2014) 0.81
The effects of inflammation, infection and antibiotics on the microbiota-gut-brain axis. Adv Exp Med Biol (2014) 0.81
Effect of probiotics on gastrointestinal function: evidence from animal models. Therap Adv Gastroenterol (2009) 0.80
Mechanisms underlying gut dysfunction in a murine model of chronic parasitic infection. Am J Physiol Gastrointest Liver Physiol (2010) 0.79
Dysregulation of peripheral cytokine production in irritable bowel syndrome. Am J Gastroenterol (2005) 0.79
Pharmabiotic manipulation of the microbiota in gastrointestinal disorders, from rationale to reality. Gastroenterol Clin North Am (2010) 0.78
Differences in intestinal microbial composition in children with IBS-what does it all mean? Am J Gastroenterol (2012) 0.78
Targeting the microbiota-gut-brain axis to modulate behavior: which bacterial strain will translate best to humans? Proc Natl Acad Sci U S A (2012) 0.78
The long-term functional consequences of acute infectious diarrhea. Curr Opin Gastroenterol (2016) 0.77
Eosinophilia is induced in the colon of Th2-sensitized mice upon exposure to locally expressed antigen. Am J Physiol Gastrointest Liver Physiol (2007) 0.76
Motility alterations in celiac disease and non-celiac gluten sensitivity. Dig Dis (2015) 0.75
Tax-deductible provisions for gluten-free diet in Canada compared with systems for gluten-free diet coverage available in various countries. Can J Gastroenterol Hepatol (2015) 0.75
[Role of enteric infections and inflammation in functional bowel disorders]. Gastroenterol Clin Biol (2002) 0.75